GSK’s GSK’227 Receives EU Orphan Drug Designation for Lung Cancer

5 days ago 5

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has announced that its B7-H3-targeted antibody-drug conjugate, GSK’227, has received Orphan Drug Desig...

1. Homepage
2. Lung Cancer
3. GSK’s GSK’227 Receives EU Orphan Drug Designation for Lung Cancer